Myles Brown

发表

CHIPS: A Snakemake pipeline for quality control and reproducible processing of chromatin profiling data

X. Shirley Liu, Len Taing, Clifford A. Meyer, 2021, F1000Research.

The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines.

Myles Brown, P. Kantoff, T. Sun, 2009, Cancer research.

Primate-specific evolution of an LDLR enhancer

Jan-Fang Cheng, Alan M. Moses, Shyam Prabhakar, 2006, Genome Biology.

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice.

Donna Neuberg, Steven M Kornblau, Johannes Köster, 2016, Cancer cell.

Nkx3-1 and LEF-1 function as transcriptional inhibitors of estrogen receptor activity.

Jun S. Song, Jun S Song, Myles Brown, 2008, Cancer research.

Positive Cross-Regulatory Loop Ties GATA-3 to Estrogen Receptor α Expression in Breast Cancer

Jérôme Eeckhoute, Mathieu Lupien, Jason S. Carroll, 2007 .

A cell-type-specific transcriptional network required for estrogen regulation of cyclin D 1 and cell cycle progression in breast cancer

Jérôme Eeckhoute, Jason S. Carroll, Myles Brown, 2006 .

A comprehensive view of nuclear receptor cancer cistromes.

Qian Wang, Tao Liu, Mathieu Lupien, 2011, Cancer research.

Polycomb-independent activity of EZH2 in castration resistant prostate cancer

Tao Liu, Housheng Hansen He, X Shirley Liu, 2013, Epigenetics & Chromatin.

Tetradian oscillation of estrogen receptor α is necessary to prevent liver lipid deposition

Alessandro Villa, Myles Brown, A. Maggi, 2012, Proceedings of the National Academy of Sciences.

p63 regulates an adhesion programme and cell survival in epithelial cells

Jason S. Carroll, Chee-Onn Leong, Myles Brown, 2006, Nature Cell Biology.

Blockade of AP-1 Potentiates Endocrine Therapy and Overcomes Resistance

Mathieu Lupien, Rinath Jeselsohn, Susan G Hilsenbeck, 2016, Molecular Cancer Research.

Emerging data on the efficacy and safety of fulvestrant, a unique antiestrogen therapy for advanced breast cancer

Myles Brown, S. Come, Sarah M Scott, 2011, Expert opinion on drug safety.

Estradiol-regulated microRNAs control estradiol response in breast cancer cells

Guohua Wang, Jason S. Carroll, Harikrishna Nakshatri, 2009, Nucleic acids research.

Cancer Positive Breast − in Pretreated Advanced Estrogen Receptor Mutations α Emergence of Constitutively Active Estrogen Receptor-Updated

Funda Meric-Bernstam, Rinath Jeselsohn, Lajos Pusztai, 2014 .

Loss of estrogen-regulated microRNA expression increases HER2 signaling and is prognostic of poor outcome in luminal breast cancer.

Myles Brown, S. Bailey, T. Westerling, 2015, Cancer research.

X chromosomal abnormalities in basal-like human breast cancer.

Shridar Ganesan, Xin Lu, Myles Brown, 2006, Cancer cell.

KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance.

Anton Simeonov, Ajit Jadhav, Nikhil Wagle, 2018, Cancer cell.

Polarity-specific activities of retinoic acid receptors determined by a co-repressor

Myles Brown, C. Glass, M. Rosenfeld, 1995, Nature.

PARP1-driven poly-ADP-ribosylation regulates BRCA1 function in homologous recombination-mediated DNA repair.

Elgene Lim, Scott B Ficarro, Jarrod A Marto, 2014, Cancer discovery.

Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-alpha and promoter-specific effects in breast cancer cells deficient in N-CoR and SMRT.

Myles Brown, E. Keeton, Erika Krasnickas Keeton, 2005, Molecular endocrinology.

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice.

Donna Neuberg, Steven M Kornblau, Johannes Köster, 2016, Cancer cell.

Response and resistance to BET bromodomain inhibitors in triple negative breast cancer

James E. Bradner, Jason S. Carroll, X. Shirley Liu, 2015, Nature.

Control of cyclin D1 and breast tumorigenesis by the EglN2 prolyl hydroxylase.

William C Hahn, David E Root, Kornelia Polyak, 2009, Cancer cell.

Molecular Determinants for the Tissue Specificity of SERMs

Myles Brown, Myles A Brown, Y. Shang, 2002, Science.

Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR–Cas9 library

Zhongzheng Cao, Han Xu, Pengfei Yuan, 2016, Nature Biotechnology.

Modeling cis-regulation with a compendium of genome-wide histone H3K27ac profiles

Shenglin Mei, Qian Qin, Chongzhi Zang, 2016, Genome research.

Epigenetic remodeling regulates transcriptional changes between ovarian cancer and benign precursors.

John Quackenbush, Henry W. Long, Brian Lawney, 2016, JCI insight.

A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer.

Jérôme Eeckhoute, Myles Brown, J. Eeckhoute, 2006, Genes & development.

Protein kinase C α is a central signaling node and therapeutic target for breast cancer stem cells.

Elgene Lim, Xi Chen, Wenjun Guo, 2013, Cancer cell.

CARM1 regulates estrogen-stimulated breast cancer growth through up-regulation of E2F1.

Mathieu Lupien, Pamela A Silver, Seth Frietze, 2008, Cancer research.

Systematic evaluation of variability in ChIP-chip experiments using predefined DNA targets.

Mark Gerstein, Kevin Struhl, Zhiping Weng, 2008, Genome research.

Advances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapy

Myles Brown, W. Shao, Wenlin Shao, 2003, Breast Cancer Research.

Integrative genomic analyses reveal clinically relevant long non-coding RNA in human cancer

Zhen Su, X. Shirley Liu, Yong Zhang, 2013 .

A closer look into DNase I hypersensitivity

Clifford A Meyer, Housheng Hansen He, X Shirley Liu, 2013, Epigenetics & Chromatin.

ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer.

Hongyun Wang, Housheng Hansen He, X Shirley Liu, 2013, The Journal of clinical investigation.

Analysis of optimized DNase-seq reveals intrinsic bias in transcription factor footprint identification

Han Xu, X. Shirley Liu, Chongzhi Zang, 2013, Nature methods.

Chromatin immunoprecipitation from fixed clinical tissues reveals tumor-specific enhancer profiles

Joaquim Bellmunt, Shirley X. Liu, Paloma Cejas, 2016, Nature Medicine.

XBP 1 Promotes Triple Negative Breast Cancer By Controlling the HIF 1 α Pathway

Mauro Ferrari, Elgene Lim, Xi Chen, 2014 .

Growth factor stimulation induces a distinct ER(alpha) cistrome underlying breast cancer endocrine resistance.

Jérôme Eeckhoute, Mathieu Lupien, Clifford A. Meyer, 2010, Genes & development.

Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated Transcription

Myles Brown, Myles A Brown, M. Lazar, 2000, Cell.